4548 On Other Exchanges
Symbol
Exchange
4548 is not on other exchanges.

seikagaku corp (4548) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SEIKAGAKU CORP (4548)

Related News

No related news articles were found.

seikagaku corp (4548) Related Businessweek News

No Related Businessweek News Found

seikagaku corp (4548) Details

Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally. The company operates through, Pharmaceuticals and LAL segments. It offers pharmaceuticals and medical devices, including intra-articular injections for improving joint functions under the brands of ARTZ, ARTZ Dispo, SUPARTZ, ARTZAL, etc.; injection medical device for treating osteoarthritis pain of the knee under the brand name of Gel-One; ophthalmic surgical aids under the brands OPEGAN and OPEGAN Hi; and surgical aid for endoscopic mucosal resection under the brand name of MucoUp. The company also provides bulk products comprising sodium hyaluronate, which is used as a raw material for the manufacturers of pharmaceuticals; and sodium chondroitin sulfate that is used as a raw material in pharmaceuticals, ophthalmic products, and drinks for nutritional fortification. In addition, it develops endotoxin-detecting reagents for use in quality control in the manufacturing process and release test of pharmaceuticals and medical devices, as well as in quality management of fluids for hemodialysis under the Pyrochrome, ENDOSPECY, TOXICOLOR, etc. brands. Further, the company develops and markets oral care products comprising mouthwash under the KINUSUI Spray brand. Additionally, its products under development include SI-6603 that is in Phase III clinical trials for lumbar disc herniation; SI-657, an additional indication of ARTZ for enthesopathy; SI-614, a therapeutic drug for dry eyes; and SI-613, a treatment for knee osteoarthritis. The company was formerly known as K.K. Seikagaku Kenkyusho and changed its name to Seikagaku Corporation in 1962. Seikagaku Corporation was founded in 1947 and is headquartered in Tokyo, Japan.

663 Employees
Last Reported Date: 06/21/16
Founded in 1947

seikagaku corp (4548) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

seikagaku corp (4548) Key Developments

Seikagaku Corp. to Report Q1, 2017 Results on Jul 28, 2016

Seikagaku Corp. announced that they will report Q1, 2017 results at 3:00 PM, Tokyo Standard Time on Jul 28, 2016

Bioventus Extends Distribution Agreement with Seikagaku Corporation

Bioventus announced it has entered into an agreement with Seikagaku Corporation to continue distributing SUPARTZ FX™ in the US after the current distribution agreement expires in May 2017. Under terms of this extension, Bioventus will continue to distribute SUPARTZ FX in the US through May 2019.

Seikagaku Corp., Annual General Meeting, Jun 21, 2016

Seikagaku Corp., Annual General Meeting, Jun 21, 2016.

 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

4548 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4548.
View Industry Companies
 

Industry Analysis

4548

Industry Average

Valuation 4548 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SEIKAGAKU CORP, please visit www.seikagaku.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.